FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Catharina Korse

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Wieneke A Buikhuisen; Jacobus A Burgers; Frank Lj Custers; Steven Jm Gans; Harry Jm Groen; Catharina M Korse; Anna K Nowak; Nick Pavlakis; J Hugo Schouwink; Franz Mnh Schramel; Wim Fm Strankinga; Rob J van Klaveren; Andrew D Vincent; Paul Baas
Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study.
Catharina M Korse; Babs G Taal; Marie-Louise F Van Velthuysen; Otto Visser
Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: Experience of two decades of cancer registry.
Catharina M Korse; Theodora C Linders; Babs G Taal; Marie-Louise F Van Velthuysen; Andrew Vincent; Paul Baas; Johanna C G M Buning-Kager; Johannes M G Bonfrer
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Catharina Korse (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Wieneke A Buikhuisen; Jacobus A Burgers; Frank Lj Custers; Steven Jm Gans; Harry Jm Groen; Catharina M Korse; Anna K Nowak; Nick Pavlakis; J Hugo Schouwink; Franz Mnh Schramel; Wim Fm Strankinga; Rob J van Klaveren; Andrew D Vincent; Paul Baas
Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study.
The lancet oncology 2013;14(6):543-51.
2013: Catharina M Korse; Babs G Taal; Marie-Louise F Van Velthuysen; Otto Visser
Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: Experience of two decades of cancer registry.
European journal of cancer (Oxford, England : 1990) 2013;49(8):1975-83.
2012: Catharina M Korse; Theodora C Linders; Babs G Taal; Marie-Louise F Van Velthuysen; Andrew Vincent; Paul Baas; Johanna C G M Buning-Kager; Johannes M G Bonfrer
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments.
European journal of cancer (Oxford, England : 1990) 2012;48(5):662-71.
2011: Catharina M Korse; M Muller; B G Taal
Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours.
British journal of cancer 2011;105(8):1173-5.
2011: Marcel P M Stokkel; Catharina M Korse; Daphne D Rietbergen; Babs G Taal
Somatostatin receptor scintigraphy and chromogranin A assay in staging and follow-up of patients with well-differentiated neuroendocrine tumors.
Nuclear medicine communications 2011;32(8):731-7.
2011: Catharina M Korse; Warner Prevoo; Paul Baas; Johannes M G Bonfrer; Babs G Taal
Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2011;32(4):647-52.
2010: Marieke A Vollebergh; Ingrid Kappers; Houke Klomp; Johanna C Buning-Kager; Catharina M Korse; Michael Hauptmann; Karin E de Visser; michel van den heuvel; Sabine C Linn
Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum biomarkers for response to epidermal growth factor receptor inhibitors in patients with advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(12):1939-48.
2010: Tjeerd S Aukema; Renato A Valdés Olmos; Catharina M Korse; Bin B R Kroon; Michel W J M Wouters; Wouter V Vogel; Johannes M G Bonfrer; Omgo E Nieweg
Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up.
Annals of surgical oncology 2010;17(6):1657-61.
2010: Barbara C van Munster; Johanna C Korevaar; Catharina M Korse; Johannes M G Bonfrer; Aeilko H Zwinderman; Sophia de Rooij
Serum S100B in elderly patients with and without delirium.
International journal of geriatric psychiatry 2010;25(3):234-9.
2010: I Kappers; H M Klomp; Catharina M Korse; L L Nieuwenhuis; H van Tinteren; N van Zandwijk; M A Vollebergh; J M G Bonfrer; michel van den heuvel
Soluble epidermal growth factor receptor (sEGFR) and carcinoembryonic antigen (CEA) concentration in patients with non-small cell lung cancer: correlation with survival after erlotinib and gefitinib treatment.
Ecancermedicalscience 2010;4():178.
2009: Catharina M Korse; Babs G Taal; Cornelis A de Groot; Robert H Bakker; Johannes M G Bonfrer
Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4293-9.
2009: Barbara C van Munster; Catharina M Korse; Sophia de Rooij; Johannes M G Bonfrer; Aeilko H Zwinderman; Johanna C Korevaar
Markers of cerebral damage during delirium in elderly patients with hip fracture.
BMC neurology 2009;9():21.
2009: Catharina M Korse; Johannes M G Bonfrer; Marc van Beurden; René H M Verheijen; Matti A Rookus
Estradiol and testosterone levels are lower after oophorectomy than after natural menopause.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2009;30(1):37-42.
2009: Catharina M Korse; Johannes M G Bonfrer; Neil K Aaronson; Augustinus A M Hart; Babs G Taal
Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.
Neuroendocrinology 2009;89(3):296-301.
2008: Alina Vrieling; Matti A Rookus; Ellen Kampman; Johannes M G Bonfrer; Astrid J Bosma; Annemieke Cats; Jaap van Doorn; Catharina M Korse; Ben J M Witteman; Flora E van Leeuwen; Laura J van't Veer; Dorien W Voskuil
No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(10):2585-93.
2008: Patric M Schiltz; Robert O Dillman; Catharina M Korse; James M Cubellis; Gregory J Lee; Gijsbert C De Gast
Lack of elevation of serum S100B in patients with metastatic melanoma as a predictor of outcome after induction with an autologous vaccine of proliferating tumor cells and dendritic cells.
Cancer biotherapy & radiopharmaceuticals 2008;23(2):214-21.
2008: michel van den heuvel; Catharina M Korse; Johannes M G Bonfrer; Paul Baas
Non-invasive diagnosis of pleural malignancies: the role of tumour markers.
Lung cancer (Amsterdam, Netherlands) 2008;59(3):350-4.
2008: Dorien W Voskuil; Alina Vrieling; Catharina M Korse; Jos H Beijnen; Johannes M G Bonfrer; Jaap van Doorn; Reinie Kaas; Hester S A Oldenburg; Nicola S Russell; E J Th Rutgers; Senno Verhoef; Flora E van Leeuwen; Laura J van't Veer; Matti A Rookus
Effects of lycopene on the insulin-like growth factor (IGF) system in premenopausal breast cancer survivors and women at high familial breast cancer risk.
Nutrition and cancer 2008;60(3):342-53.
2007: Alina Vrieling; Dorien W Voskuil; Johannes M G Bonfrer; Catharina M Korse; Jaap van Doorn; Annemieke Cats; Annekatrien C Depla; Robin Timmer; Ben J M Witteman; Flora E van Leeuwen; Laura J van't Veer; Matti A Rookus; Ellen Kampman
Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer.
The American journal of clinical nutrition 2007;86(5):1456-62.
2007: Alina Vrieling; Matti A Rookus; Ellen Kampman; Johannes M G Bonfrer; Catharina M Korse; Jaap van Doorn; Johanna W Lampe; Annemieke Cats; Ben J M Witteman; Flora E van Leeuwen; Laura J van't Veer; Dorien W Voskuil
Isolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer risk.
The Journal of nutrition 2007;137(2):379-83.
2007: Guy S Missotten; Catharina M Korse; C van Dehn; T C Linders; Jan E E Keunen; Martine J Jager; Johannes M G Bonfrer
S-100B protein and melanoma inhibitory activity protein in uveal melanoma screening. A comparison with liver function tests.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2007;28(2):63-9.
2005: Léonie H M Smit; Omgo E Nieweg; Catharina M Korse; Johannes M G Bonfrer; Bin B R Kroon
Significance of serum S-100B in melanoma patients before and after sentinel node biopsy.
Journal of surgical oncology 2005;90(2):66-9; discussion 69-70.
2005: Léonie H M Smit; Catharina M Korse; Augustinus A M Hart; Johannes M G Bonfrer; John B A G Haanen; J Martijn Kerst; Omgo E Nieweg; Gijsbert C De Gast
Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients.
European journal of cancer (Oxford, England : 1990) 2005;41(3):386-92.
2005: Léonie H M Smit; Catharina M Korse; Johannes M G Bonfrer
Comparison of four different assays for determination of serum S-100B.
The International journal of biological markers 2005;20(1):34-42.
2004: Johanna M Zuetenhorst; Catharina M Korse; Johannes M G Bonfrer; Ellen Peter; Cornelis B H W Lamers; Babs G Taal
Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumors.
Clinical chemistry 2004;50(9):1634-9.
2004: Johanna M Zuetenhorst; Catharina M Korse; Johannes M G Bonfrer; R H Bakker; Babs G Taal
Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease.
British journal of cancer 2004;90(11):2073-9.
2003: Guy S Missotten; Nancy E M L Tang; Catharina M Korse; H Monique H Hurks; Didi de Wolff-Rouendaal; Jan E E Keunen; Martine J Jager; Johannes M G Bonfrer
Prognostic value of S-100-beta serum concentration in patients with uveal melanoma.
Archives of ophthalmology 2003;121(8):1117-9.
2003: G J J van Doornum; Catharina M Korse; J C G M Buning-Kager; Johannes M G Bonfrer; S Horenblas; Babs G Taal; J Dillner
Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites.
British journal of cancer 2003;88(7):1095-100.
2003: Johanna M Zuetenhorst; Johannes M G Bonfrer; Catharina M Korse; Rob Bakker; Harm van Tinteren; Babs G Taal
Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor.
Cancer 2003;97(7):1609-15.
2003: A P Hamberg; Catharina M Korse; Johannes M G Bonfrer; Gijsbert C De Gast
Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma.
Melanoma research 2003;13(1):45-9.
2003: Marleen Kok; Johannes M G Bonfrer; Catharina M Korse; Daphne de Jong; Marie José Kersten
Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2003;24(1):53-60.
2003: Serge van Ruth; Olaf van Tellingen; Catharina M Korse; Vic J Verwaal; Frans A N Zoetmulder
Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymoma.
Anti-cancer drugs 2003;14(1):57-65.
2001: Johannes M G Bonfrer; Catharina M Korse
Monitoring malignant melanoma with the S-100B tumour marker.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2001;158():149-57.
2000: Katja N Gaarenstroom; Gemma G Kenter; Johannes M G Bonfrer; Catharina M Korse; M J Van de Vijver; Gert Jan Fleuren; J Baptist Trimbos
Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
Gynecologic oncology 2000;77(1):164-70.
1999: Hugo Schouwink; Catharina M Korse; Johannes M G Bonfrer; Augustinus A M Hart; Paul Baas
Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma.
Lung cancer (Amsterdam, Netherlands) 1999;25(1):25-32.
1999: Johannes M G Bonfrer; Catharina M Korse
TPA and CA 15.3 measurements for breast cancer monitoring in a routine setting.
The International journal of biological markers 1999;14(1):40-4.
1998: Johannes M G Bonfrer; Catharina M Korse; Omgo E Nieweg; Elaine M Rankin
The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma.
British journal of cancer 1998;77(12):2210-4.
1997: Johannes M G Bonfrer; Catharina M Korse; S P Israels
Serum S-100 has prognostic significance in malignant melanoma.
Anticancer research 1997;17(4B):2975-7.
1997: Johannes M G Bonfrer; J Hugo Schouwink; Catharina M Korse; Paul Baas
Cyfra 21-1 and TPA as markers in malignant mesothelioma.
Anticancer research 1997;17(4B):2971-3.
1997: Katja N Gaarenstroom; Johannes M G Bonfrer; Catharina M Korse; Gemma G Kenter; Peter Kenemans
Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancer.
Anticancer research 1997;17(4B):2955-8.
1997: Johannes M G Bonfrer; Katja N Gaarenstroom; Catharina M Korse; BN Van Bunningen; Peter Kenemans
Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
Anticancer research 1997;17(3C):2329-34.
1997: Johannes M G Bonfrer; Catharina M Korse; Rob A Verstraeten; Gerard J van Kamp; Guus A M Hart; Peter Kenemans
Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference value.
Clinical chemistry 1997;43(3):491-7.
1997: Johannes M G Bonfrer; T C Linders; P C Hageman; John Hilkens; Catharina M Korse; C F Molthoff
Effect of paclitaxel (Taxol) on CA 125 expression and release by ovarian cancer cell lines.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1997;18(4):232-40.
1995: Katja N Gaarenstroom; Johannes M G Bonfrer; Gemma G Kenter; Catharina M Korse; Augustinus A M Hart; J Baptist Trimbos; Theo J M Helmerhorst
Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.
Cancer 1995;76(5):807-13.
1995: Peter Bruning; Jaap van Doorn; J M Bonfrèr; Paulus A H van Noord; Catharina M Korse; T C Linders; Augustinus A M Hart
Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer.
International journal of cancer. Journal international du cancer 1995;62(3):266-70.
1994: Johannes M G Bonfrer; Katja N Gaarenstroom; Gemma G Kenter; Catharina M Korse; Augustinus A M Hart; M P Gallee; Theo J M Helmerhorst; Peter Kenemans
Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer.
Gynecologic oncology 1994;55(3 Pt 1):371-5.
1994: Katja N Gaarenstroom; Gemma G Kenter; Johannes M G Bonfrer; Catharina M Korse; M P Gallee; Augustinus A M Hart; M Müller; J Baptist Trimbos; Theo J M Helmerhorst
Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer.
Cancer 1994;74(8):2307-13.
1994: Johannes M G Bonfrer; E M Groeneveld; Catharina M Korse; A van Dalen; Lauran Oomen; D Ivanyi
Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1994;15(4):210-22.